Skip to content

Clinical study on acupuncture and moxibustion in the treatment of mild cognitive impairment

Clinical study on acupuncture and moxibustion in the treatment of mild cognitive impairment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-16009144
Enrollment
Unknown
Registered
2016-08-26
Start date
2016-09-20
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitve Impairment

Interventions

Moxibustion Sham Group :Moxibustion
Acupoint group :Acupuncture
Acupuncture Sham Group :Acupuncture
Moxibustion Healthy Subjects :Moxibustion

Sponsors

First Affiliated Hospital, Guangxi University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with MCI diagnostic criteria consistent; 2. the existence of memory impairment (private prosecution and insider confirmed); 3. aged 55 to 75 years; 4. other cognitive functions relative to normal or mild impairment; 5. the ability of daily life and the social occupation unaffected; 6. the memory of the damage has not yet reached the diagnostic criteria for dementia; 7. exclude any other diseases that can cause brain dysfunction; 8. the subjects or guardians signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Other serious primary diseases, such as liver, kidney and other diseases; 2. Severe hearing, visual impairment, can not cope with the assessment; 3. Patients with active epilepsy; 4. Previous history of mental illness; 5. Dementia with cerebral infarction or any of the physical and mental disorders that can lead to functional disorders of the brain; 6. Use of other drugs that may cause changes in cognitive function or heart and brain and other important organ failure; 7. Excluding standard does not meet the inclusion criteria, or in accordance with the inclusion criteria, but not for a variety of reasons for the implementation of acupuncture or drug observation of patients.

Design outcomes

Primary

MeasureTime frame
ADC;resting-state fMRI;MRS;Hcy;8-iso-PGF 2a;

Countries

China

Contacts

Public ContactLihua Zhao

First Affiliated Hospital, Guangxi University of Chinese Medicine

zhaolh67@163.com+86 13006913108

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 18, 2026